Mangalam Drugs & Organics is currently trading at its upper limit of Rs. 23.90, up by 1.10 points or 4.82% from its previous closing of Rs. 22.80 on the BSE.
The scrip opened at Rs. 23.90 and has touched a high and low of Rs. 23.90 and Rs. 23.90 respectively.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 60.15 on 25-Mar-2019 and a 52 week low of Rs. 20.40 on 19-Mar-2020.
Last one week high and low of the scrip stood at Rs. 23.90 and Rs. 20.40 respectively. The current market cap of the company is Rs. 37.83 crore.
The promoters holding in the company stood at 50.53%, while Institutions and Non-Institutions held 0.08% and 49.39% respectively.
Mangalam Drugs and Organics is gearing up production of Hydroxrychloroquine Sulphate (HCQS) and Chloroquine Phosphate (CQP) APIs to meet the demand in case these APIs are approved for treatment of patients affected by Coronavirus Disease (COVID-19) by regulatory authorities and safeguard lives of affected in these challenging times.
Mangalam Drugs and Organics manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.